![Michael Andriole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Andriole
Chief Executive Officer at
Artios Pharma Ltd.
Profile
Michael T.
Andriole currently works at Artios Pharma Ltd., as Chief Executive Officer & Director from 2025.
Mr. Andriole also formerly worked at Chimerix, Inc., as President, Chief Executive Officer & Director from 2023 to 2025, Eli Lilly & Co., as Vice President-Corporate Business Development from 2014 to 2017, and Endocyte, Inc., as Chief Financial Officer from 2017 to 2018.
Mr. Andriole received his Masters Business Admin degree from Kelley School of Business and undergraduate degree from Williams College of Business.
Michael Andriole active positions
| Companies | Position | Start |
|---|---|---|
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Chief Executive Officer | 12/08/2025 |
Former positions of Michael Andriole
| Companies | Position | End |
|---|---|---|
| CHIMERIX, INC. | Chief Executive Officer | 21/04/2025 |
| ENDOCYTE, INC. | Director of Finance/CFO | 01/12/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2017 |
Training of Michael Andriole
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Williams College of Business
 Williams College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Michael Andriole
